Minder® System Cleared for Patients 12 -75 Years of Age Highlights: • The U.S. Food and Drug Administration (FDA) has cleared the Minder® System to include patients aged 12 years and older with drug-resistant epilepsy, broadening eligible access beyond the original clearance for patients 18...